3 studies found for:    "hereditary leiomyomatosis and renal cell cancer"
Show Display Options
Rank Status Study
1 Recruiting A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
Conditions: HLRCC;   Metastatic Papillary RCC
Interventions: Drug: Bevacizumab;   Drug: Erlotinib
2 Active, not recruiting Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin
Conditions: Cutaneous Leiomyomas;   Hereditary Leiomyomatosis and Renal Cell Cancer
Interventions: Biological: Botulinum toxin type A;   Other: Placebo
3 Recruiting Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
Conditions: Leiomyomatosis;   Kidney Neoplasms
Intervention:

Indicates status has not been verified in more than two years